• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[川崎病冠状动脉瘤的两种超声心动图诊断标准分析]

[Analysis of 2 diagnostic criteria of echocardiography for coronary artery aneurysm in Kawasaki disease].

作者信息

Liu W Q, Xia B, Fan W, Yu Z, Lin W L, Chen L, Wang C, Liu B N, Li J, Yang Jun

机构信息

Department of Ultrasonography, Shenzhen Children's Hospital, Shenzhen 518038, China.

Department of Cardiovascular Medicine, Shenzhen Children's Hospital, Shenzhen 518038, China.

出版信息

Zhonghua Er Ke Za Zhi. 2022 Jun 2;60(6):588-593. doi: 10.3760/cma.j.cn112140-20220316-00205.

DOI:10.3760/cma.j.cn112140-20220316-00205
PMID:35658368
Abstract

To analyze the difference between Z score and previous criteria in the diagnosis characteristics of coronary artery aneurysm (CAA) in Kawasaki disease, and to investigate the clinical distribution of Kawasaki disease CAA in the Z score group. This study retrospectively analyzed the clinical and echocardiographic data of 2 419 children with Kawasaki disease in Shenzhen Children's Hospital from January 2009 to December 2019. The traditional criteria and Z score criteria were used to diagnose CAA, and the differences of diagnostic efficiency between the 2 diagnostic methods were analyzed. The clinical distribution characteristics of CAA in children with Kawasaki disease were analyzed by grouping their sex, clinical classification (complete Kawasaki disease, incomplete Kawasaki disease) the sensitivity to intravenous immunoglobulin (IVIG) (IVIG-sensitive Kawasaki disease,IVIG-unresponsive Kawasaki disease). And the course of the disease (≤6 weeks, >6-8 weeks, >8 weeks to 6 months) etc. The χ² test or Kruskal-Wallis test was used for comparison between the groups, and the Kappa test was used for consistency evaluation. Among the 2 419 children with Kawasaki disease, 1 558 were males and 861 were females. The age of onset was 1.8 (1.0, 3.2) years. The rate of CAA by Z score criteria was higher than that by traditional method (21.9% (529/2 419) 13.9% (336/2 419), χ=1 074.94, 0.001). Compared to the traditional method, the Z score criteria found higher rate of CAA in male patients, patients with incomplete Kawasaki disease, and IVIG-unresponsive patients (25.2% (392/1 558) 16.0% (249/1 558), (32.7% (166/507) 19.5% (99/507), 30.5% (95/312) 24.0% (75/312), χ=694.05, 216.19, 184.37, all 0.001). The Z score criteria was consistent with the traditional method in diagnosing CAA (κ=0.642,<0.001). Moreover, in the Z score criteria, the rate of CAA in males (25.2%, 392/1 558) was higher than that in females (15.9%, 137/861), higher in incomplete Kawasaki cases (32.7%, 166/507) than that in complete Kawasaki case (19.0%, 363/1 912), and higher in IVIG-unresponsive cases (30.4%, 95/312) than that in IVIG-sensitive cases (20.6%, 434/2 107), with statistically significant differences (χ=27.76, 44.38, 15.43, all <0.001). Coronary Z score of course ≤ 6 weeks was greater than that of course between>6-8 weeks and >8 weeks to 6 months (1.3 (0.7, 2.3) 0.7 (0.3, 1.4), 0.7 (0.3, 1.3), 20.65, 13.70, both 0.001). The rate of CAA in Kawasaki disease by Z score criteria is higher than that by traditional method. In the Z score group, most CAA occur within 6 weeks of the course of the disease, and the rate of CAA in male, incomplete Kawasaki disease, and IVIG-unresponsive is higher.

摘要

分析Z评分与既往标准在川崎病冠状动脉瘤(CAA)诊断特征上的差异,并探讨Z评分组川崎病CAA的临床分布情况。本研究回顾性分析了2009年1月至2019年12月在深圳儿童医院就诊的2419例川崎病患儿的临床和超声心动图资料。采用传统标准和Z评分标准诊断CAA,分析两种诊断方法诊断效率的差异。通过对川崎病患儿的性别、临床分型(完全性川崎病、不完全性川崎病)、对静脉注射免疫球蛋白(IVIG)的敏感性(IVIG敏感型川崎病、IVIG无反应型川崎病)以及病程(≤6周、>6 - 8周、>8周至6个月)等进行分组,分析川崎病CAA的临床分布特征。组间比较采用χ²检验或Kruskal - Wallis检验,一致性评价采用Kappa检验。在2419例川崎病患儿中,男性1558例,女性861例。发病年龄为1.8(1.0,3.2)岁。Z评分标准诊断CAA的发生率高于传统方法(21.9%(529/2419)对13.9%(336/2419),χ = 1074.94,P < 0.001)。与传统方法相比,Z评分标准在男性患者、不完全性川崎病患者和IVIG无反应患者中发现CAA的发生率更高(25.2%(392/1558)对16.0%(249/1558),(32.7%(166/507)对19.5%(99/507),30.5%(95/312)对24.0%(75/312),χ = 694.05,216.19,184.37,P均 < 0.001)。Z评分标准与传统方法在诊断CAA方面具有一致性(κ = 0.642,P < 0.001)。此外,在Z评分标准中,男性CAA发生率(25.2%,392/1558)高于女性(15.9%,137/861),不完全性川崎病病例(32.7%,166/507)高于完全性川崎病病例(19.0%,363/1912),IVIG无反应病例(30.4%,95/312)高于IVIG敏感病例(20.6%,434/2107),差异均有统计学意义(χ = 27.76,44.38,15.43,P均 < 0.001)。病程≤6周的冠状动脉Z评分大于病程在>6 - 8周和>8周至6个月之间的(1.3(0.7,2.3)对0.7(0.3,1.4),0.7(0.3,1.3),χ = 20.65,13.70,P均 < 0.001)。Z评分标准诊断川崎病CAA的发生率高于传统方法。在Z评分组中,大多数CAA发生在病程6周内,男性、不完全性川崎病和IVIG无反应者CAA发生率更高。

相似文献

1
[Analysis of 2 diagnostic criteria of echocardiography for coronary artery aneurysm in Kawasaki disease].[川崎病冠状动脉瘤的两种超声心动图诊断标准分析]
Zhonghua Er Ke Za Zhi. 2022 Jun 2;60(6):588-593. doi: 10.3760/cma.j.cn112140-20220316-00205.
2
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.川崎病冠状动脉瘤:美国人群中进展性疾病和不良心脏事件的危险因素。
J Am Heart Assoc. 2016 Sep 15;5(9):e003289. doi: 10.1161/JAHA.116.003289.
3
Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.川崎病患者冠状动脉瘤严重程度与后期冠状动脉事件风险的相关性研究。
JAMA Pediatr. 2018 May 7;172(5):e180030. doi: 10.1001/jamapediatrics.2018.0030.
4
Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.川崎病伴低丙种球蛋白血症静脉用免疫球蛋白抵抗风险的冠状动脉瘤危险因素:POST-RAISE 分析。
J Pediatr. 2022 Jan;240:158-163.e4. doi: 10.1016/j.jpeds.2021.08.065. Epub 2021 Aug 27.
5
Comparison of six Z-score formulas based on echocardiography for coronary artery lesions in Kawasaki disease.基于超声心动图的 6 种 Z 评分公式对川崎病冠状动脉病变的比较。
Int J Cardiol. 2024 Aug 15;409:132102. doi: 10.1016/j.ijcard.2024.132102. Epub 2024 Apr 27.
6
Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.对免疫球蛋白临床反应良好的川崎病患者冠状动脉瘤的延迟发生
J Pediatr. 2020 Dec;227:224-230.e3. doi: 10.1016/j.jpeds.2020.08.032. Epub 2020 Aug 15.
7
[Retrospective analysis of infliximab in the treatment of Kawasaki disease].英夫利昔单抗治疗川崎病的回顾性分析
Zhonghua Er Ke Za Zhi. 2022 Jan 2;60(1):14-19. doi: 10.3760/cma.j.cn112140-20210713-00576.
8
Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.英夫利昔单抗用于强化川崎病和冠状动脉瘤患者的初始治疗。
Arch Dis Child. 2023 Oct;108(10):833-838. doi: 10.1136/archdischild-2023-325639. Epub 2023 May 31.
9
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.多中心、随机、开放标签、盲终点评估的皮质类固醇加静脉注射免疫球蛋白(IVIG)和阿司匹林与 IVIG 和阿司匹林预防川崎病(KD)冠状动脉瘤(CAA)的试验:KD CAA 预防(KD-CAAP)试验方案。
Trials. 2023 Jan 26;24(1):60. doi: 10.1186/s13063-022-07051-9.
10
The Harada score in the US population of children with Kawasaki disease.美国川崎病患儿群体中的原田评分。
Hosp Pediatr. 2014 Jul;4(4):233-8. doi: 10.1542/hpeds.2014-0008.

引用本文的文献

1
Kawasaki disease involving both the nervous system and cardiovascular system: a case report and literature review.川崎病累及神经系统和心血管系统:一例病例报告及文献综述
Front Pediatr. 2024 Dec 2;12:1459143. doi: 10.3389/fped.2024.1459143. eCollection 2024.